Solitary Fibrous Tumor
Symptoms, Doctors, Treatments, Advances & More

Learn About Solitary Fibrous Tumor

What is the definition of Solitary Fibrous Tumor?

Solitary fibrous tumor (SFT) is a noncancerous tumor of the lining of the lung and chest cavity, an area called the pleura. SFT used to be called localized fibrous mesothelioma.

What are the alternative names for Solitary Fibrous Tumor?

Mesothelioma - benign; Mesothelioma - fibrous; Pleural fibroma

What are the causes of Solitary Fibrous Tumor?

The exact cause of SFT remains unknown. This type of tumor affects men and women equally.

What are the symptoms of Solitary Fibrous Tumor?

About one half of the people with this type of tumor do not show any symptoms.

If the tumor grows to a large size and pushes on the lung, it can lead to symptoms, such as:

  • Chest pain
  • Chronic cough
  • Shortness of breath
  • Clubbed appearance of the fingers
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Solitary Fibrous Tumor?

SFT is usually treated by removing the tumor.

Who are the top Solitary Fibrous Tumor Local Doctors?
Elite in Solitary Fibrous Tumor
Elite in Solitary Fibrous Tumor
Referral may be required
Milan, IT 

Silvia Stacchiotti practices practicing medicine in Milan, Italy. Ms. Stacchiotti is rated as an Elite expert by MediFind in the treatment of Solitary Fibrous Tumor. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Solitary Fibrous Tumor, Adult Soft Tissue Sarcoma, Hemangioendothelioma, Epithelioid Sarcoma, and Synovectomy.

Elite in Solitary Fibrous Tumor
General Surgery
Elite in Solitary Fibrous Tumor
General Surgery
Referral may be required

The Johns Hopkins Hospital

1800 Orleans Street, 
Baltimore, MD 
Languages Spoken:
English
Accepting New Patients

John Gross is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Gross is rated as an Elite provider by MediFind in the treatment of Solitary Fibrous Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Solitary Fibrous Tumor, Fibrosarcoma, Liposarcoma, and Tissue Biopsy. Dr. Gross is board certified in American Board Of Pathology. Dr. Gross is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Solitary Fibrous Tumor
Hand Surgery | Orthopedics | Sports Medicine
Advanced in Solitary Fibrous Tumor
Hand Surgery | Orthopedics | Sports Medicine
Referral may be required

Aligned Orthopedic Partners

10215 Fernwood Road, Suite 506, 
Bethesda, MD 
Languages Spoken:
English
Offers Telehealth

Edward Bieber is an Orthopedics specialist and a Sports Medicine provider practicing medicine in Bethesda, Maryland. Dr. Bieber is rated as an Advanced provider by MediFind in the treatment of Solitary Fibrous Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Synovitis, Tendinitis, Tenosynovitis, and Trigger Thumb. Dr. Bieber is board certified in Abos.

What is the outlook (prognosis) for Solitary Fibrous Tumor?

The outcome is expected to be good with prompt treatment. In rare cases, the tumor may return.

What are the possible complications of Solitary Fibrous Tumor?

Fluid escaping into the membranes around the lungs (pleural effusion) is a complication.

When should I contact a medical professional for Solitary Fibrous Tumor?

Contact your provider for an appointment if you notice symptoms of SFT.

What are the latest Solitary Fibrous Tumor Clinical Trials?
A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations

Summary: Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring anaplastic lymphoma kinase (ALK), receptor tyrosine kinase encoded by the gene ROS1 (ROS1), or neurotrophic receptor kinase genes encoding TRK kinase family (NTRK1-3) alterations to estimate the Maximum Tolerated Dose (...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1, Open-label, Multicenter, Dose-escalation and Cohort Expansion Study of OKN4395, a Triple Antagonist of EP2, EP4, and DP1 Prostanoid Receptors, as Monotherapy and in Combination With Pembrolizumab, in Patients With Advanced Solid Tumors

Summary: The purpose of this study is to investigate the study drug, OKN4395, administered alone and in combination with pembrolizumab. The overall objectives of this study are to determine the safety and tolerability (degree to which side effects of a drug can be tolerated) of OKN4395 alone and in combination with pembrolizumab, OKN4395 and metabolites (broken-down substances) of OKN4395 levels in the blo...

Who are the sources who wrote this article ?

Published Date: August 19, 2024
Published By: Allen J. Blaivas, DO, Division of Pulmonary, Critical Care, and Sleep Medicine, VA New Jersey Health Care System, Clinical Assistant Professor, Rutgers New Jersey Medical School, East Orange, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Kaidar-Person O, Zagar T, Haithcock BE, Weiss, J. Diseases of the pleura and mediastinum. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 70.

Konopka K, Arenberg DA. Benign lung tumors. In: Broaddus VC, Ernst JD, King Jr TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 80.